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GENERAL COMMENTS This is an interesting study with the potential to answer an important 
question about the direction of causation between smoking and 
psychological disorders. There are two main limitations: 
1) Power - Null conclusions from Mendelian randomization studies 
are typically limited by power. This is because genetic variants do 
not explain much of the variation in risk factors. In this case, the 
expected per allele genetic association of the variant with the 
outcome based on the observational association was an odds ratio 
of 1.03. There are reasons one may expect a stronger genetic 
association than the observational association if there were a true 
causal link; however, these are speculative and depend on the 
function of the genetic variant. The genetic associations observed 
are therefore compatible with the (positive) observational 
associations, meaning that the null result could reflect a lack of 
power to detect a true effect. On the other hand, a more conclusive 
Mendelian randomization study addressing this question is unlikely 
to be performed in the medium- to long-term future. This analysis 
included a genetic variant in the gene region having by far the 
strongest association with smoking-related exposures, and have a 
total sample size of 125,000+. The addition of even 20,000 
participants (say) is highly unlikely to change the results of this 
investigation substantially. 
2) Function of the genetic variant - The analysis uses a single 
genetic variant. While this has definite benefits in terms of plausibility 
of the Mendelian randomization assumptions (the specific 
association of the variant with smoking-related exposures has 
scientific merit, and assessing the instrumental variable assumptions 
is only required for a single variant), there are also points to take 
note. In particular, the genetic variant assesses the causal nature of 
the aspects of smoking-related exposures associated with the 
variant. For example, the strongest effect of the variant is on cotinine 
levels. Is it plausible that cotinine is the major mediator of the 
genetic association with depression/anxiety? Or could we have 
missed the true cause linking smoking with depression/anxiety? 
3) Another limitation in terms of impact, is that these data (and 
hence the results) overlap largely with reference 38. 
Major points: 
1. The statement "...in a British cohort, the rs16969968 variant was 
associated with decreased depression [39] during pregnancy in 
women who smoked prior to pregnancy." is odd, especially in 
conjunction with the further statement "These findings are not 
consistent with a causal role of smoking in increasing depression or 
anxiety, but are inconclusive with respect to smoking decreasing 
depression." At face value, the association of the rs16969968 
variant with decreased depression is entirely relevant to the 
discussion at hand. The conclusion that this finding (which is similar 
to that assessed by the investigators in this paper) is "inconclusive 
with respect to smoking decreasing depression" therefore requires 
some more unpacking. While I have read the authors' explanation, 
there is an element to me of the authors picking a plausible story to 
fit the data, rather than the conclusion coming clearly from the data. 
Either way, this statement is currently difficult to understand in the 
context of the paper, and requires some unwrapping. 
2. "Therefore if higher levels of smoking did cause depression or 
anxiety, we might expect the effects of rs16969968/rs1051730 to be 
considerably larger than those seen observationally per cigarette per 
day." As stated above, this is speculative (but I wouldn't remove the 
sentence for this reason alone), and also it only makes sense if 
cotinine is the likely mediator of the genetic association of smoking 
with psychological disorders. Is this plausible? 
I'd like to see a graph of associations of the genetic variant with 
smoking related variables - the per allele associations with cigarettes 
per day, smoking onset, smoking duration, cotinine levels etc. I think 
this would make clearer the true interpretation of the genetic 
association with the outcome, in terms of showing what the gene 
does and so what we are comparing in the comparison of the 
genetic groups. It would also be good to include other non-
smokingrelated 
variables in such a graph, to assess the instrumental variable 
assumptions that the genetic variant is specifically associated with 
smoking-related exposures. 
Minor points: 
3a. The forest plots will be unreadable at print size. Suggest a 
summarized figure comparing the "expected" genetic associations 
based on the observational evidence, with the measured genetic 
associations. The forest plots could then become Supplementary 
Figures. 
3b. Similar summarized figures could be provided for the sexspecific 
analyses, and for the sensitivity analyses omitting the HUNT 
study and the study of reference 39, so that the results were 
provided for reference (rather than "results not shown" - if the time 
has been taken to produce the results, it would seem that little 
additional effort would be required to present the results). 
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GENERAL COMMENTS This study investigates the causal relationship of smoking heaviness 
with depression and anxiety using Mendelian randomization meta 
analysis. The main strengths of this paper include the use of 
Mendelian randomization approach (using genetic variants linked to 
smoking heaviness) which are less susceptible to confounding and 
reverse causation commonly found in observational studies; and the 
large sample size, which is crucial for a meaningful Mendelian 
randomization analysis. As such, this paper may provide more 
credible evidence on this topic. The following are some suggestions 
which may improve the paper. 
Major comments 
For a valid Mendelian randomization analysis, certain assumptions 
have to be fulfilled. The authors should describe in more details how 
these assumptions were assessed in the Methods, or if they were 
assessed previously, corresponding references should be provided. 
The absence of pleotropy, one of these assumptions, is not depicted 
in Figure 1. 
Mendelian randomization analysis can be implemented in two ways, 
1) Using genetic polymorphisms as proxies of exposure; or 2) 
Instrumental variable analysis using genetic polymorphisms as 
instrument. There has been some discussion on the utility of these 
approaches recently (Methodological challenges in Mendelian 
randomization published in Epidemiology, 2014). Can the authors 
explain why they choose the first approach over the second 
approach in this study? 
The observational analysis is highly prone to confounding as only a 
few factors were adjusted for in this analysis. Therefore, even the 
result of a meta analysis is likely to be biased by methodological 
issues described in the Introduction. Can the authors adjust for more 
potential confounders such as sociodemographic factors in each of 
the study included? 
Minor comments 
As the Mendelian randomization analysis only showed smoking 
heaviness (not smoking status) not associated with depression and 
anxiety among smokers, the conclusion in the abstract should be 
rephrased for better clarity. 
Inconsistencies in referencing style in the reference list, and typos in 
the author (Davey Smith G instead of Smith GD) 
 VERSION 1 – AUTHOR RESPONSE 
Reviewer: 1: 
Power - Null conclusions from Mendelian randomization studies are typically limited by power. This is 
because genetic variants do not explain much of the variation in risk factors. In this case, the 
expected per allele genetic association of the variant with the outcome based on the observational 
association was an odds ratio of 1.03. There are reasons one may expect a stronger genetic 
association than the observational association if there were a true causal link; however, these are 
speculative and depend on the function of the genetic variant. The genetic associations observed are 
therefore compatible with the (positive) observational associations, meaning that the null result could 
reflect a lack of power to detect a true effect. On the other hand, a more conclusive Mendelian 
randomization study addressing this question is unlikely to be performed in the medium- to long-term 
future. This analysis included a genetic variant in the gene region having by far the strongest 
association with smoking-related exposures, and have a total sample size of 125,000+. The addition 
of even 20,000 participants (say) is highly unlikely to change the results of this investigation 
substantially. 
We agree with the reviewers’ comments. This is a limitation of the study, and we now discuss 
this in some detail. One page 19, we say: 
“Despite this, we did not have the power to rule out the possibility of a causal effect. A 
substantial increase in sample size would be required to be confident that what we observe is 
a true null association in smokers. We hope that our estimates may be combined with those of 
further studies addressing the same question in future meta-analyses, to provide more 
definitive answers.” 
Function of the genetic variant - The analysis uses a single genetic variant. While this has definite 
benefits in terms of plausibility of the Mendelian randomization assumptions (the specific association 
of the variant with smoking-related exposures has scientific merit, and assessing the instrumental 
variable assumptions is only required for a single variant), there are also points to take note. In 
particular, the genetic variant assesses the causal nature of the aspects of smoking-related 
exposures associated with the variant. For example, the strongest effect of the variant is on cotinine 
levels. Is it plausible that cotinine is the major mediator of the genetic association with 
depression/anxiety? Or could we have missed the true cause linking smoking with 
depression/anxiety? 
Yes- we believe that cotinine is likely to be the major mediator of this association, but only 
because it is a marker of tobacco exposure, not through an independent pathway. The genetic 
variant we use is in a gene encoding a nicotinic receptor subunit. Therefore, it is unlikely to 
affect nicotine metabolism directly. Any effect on cotinine (a metabolite of nicotine) conferred 
by the variant is therefore likely to be due to differences in tobacco intake rather than nicotine 
metabolism. We have expanded on this point on page 10. 
“The rs16969968 variant is functional and leads to an amino acid change (D398N) in nicotinic 
receptor alpha5 subunit protein 33. The minor (risk) allele of this variant is associated with an 
average increase in smoking amount of one cigarette per day in smokers, and even more 
strongly associated with increases in cotinine (a metabolite of nicotine) levels 31 34 35. 
However, 
given the known role of the variant in altering receptor function 33, it is likely that the greater 
variance explained for cotinine levels is due to this measure better capturing total tobacco 
exposure, and not because the variant directly affects nicotine metabolism 31.” 
Another limitation in terms of impact, is that these data (and hence the results) overlap largely with 
reference 38. 
We agree, although our sample size is substantially larger, and therefore the estimates we 
report correspondingly more precise. In addition, the results without the HUNT study are 
provided in supplementary material (Figure S6). 
The statement "...in a British cohort, the rs16969968 variant was associated with decreased 
depression [39] during pregnancy in women who smoked prior to pregnancy." is odd, especially in 
conjunction with the further statement "These findings are not consistent with a causal role of smoking 
in increasing depression or anxiety, but are inconclusive with respect to smoking decreasing 
depression." At face value, the association of the rs16969968 variant with decreased depression is 
entirely relevant to the discussion at hand. The conclusion that this finding (which is similar to that 
assessed by the investigators in this paper) is "inconclusive with respect to smoking decreasing 
depression" therefore requires some more unpacking. While I have read the authors' explanation, 
there is an element to me of the authors picking a plausible story to fit the data, rather than the 
conclusion coming clearly from the data. Either way, this statement is currently difficult to understand 
in the context of the paper, and requires some unwrapping. 
We have amended this sentence to read: 
“These findings are not consistent with a causal role of smoking in increasing depression or 
anxiety” 
"Therefore if higher levels of smoking did cause depression or anxiety, we might expect the effects of 
rs16969968/rs1051730 to be considerably larger than those seen observationally per cigarette per 
day." As stated above, this is speculative (but I wouldn't remove the sentence for this reason alone), 
and also it only makes sense if cotinine is the likely mediator of the genetic association of smoking 
with psychological disorders. Is this plausible? 
As explained above, we think cotinine is likely to be the mediator of this association because it 
is a marker of tobacco consumption. The bias in effect sizes that can arise from using 
selfreported 
measures of tobacco exposure (e.g., cigarettes per day) has been illustrated in a 
recent paper by VanderWeele and colleagues. We have added this to the discussion: 
“It has been demonstrated that using cigarettes per day as an intermediate variable in 
Mendelian randomisation analyses using rs16969968/rs1051730 can lead to large biases in 
causal effect size estimates 49.” 
I'd like to see a graph of associations of the genetic variant with smoking related variables - the per 
allele associations with cigarettes per day, smoking onset, smoking duration, cotinine levels etc. I 
think this would make clearer the true interpretation of the genetic association with the outcome, in 
terms of showing what the gene does and so what we are comparing in the comparison of the genetic 
groups. It would also be good to include other non-smoking-related variables in such a graph, to 
assess the instrumental variable assumptions that the genetic variant is specifically associated with 
smoking-related exposures. 
We do not think that this is necessary given the robust published evidence for the association 
between rs16969968/rs1051730 and smoking heaviness as assessed by cigarettes per day and 
cotinine (see Ware et al. 2011, Munafò et al. 2012). This variant does not show robust evidence 
for associations with other smoking phenotypes (e.g., smoking initiation). We have discussed 
the fact that this genetic variant is an instrument for smoking heaviness and not initiation in 
the manuscript. Producing a table of potential confounders would be difficult as likely 
confounders are not assessed in all or in the same way across the CARTA studies. In addition, 
there is good evidence from previous publications, including the HUNT study, that the variant 
is not associated with measured confounders. We have mentioned this in the introduction. 
The forest plots will be unreadable at print size. Suggest a summarized figure comparing the 
"expected" genetic associations based on the observational evidence, with the measured genetic 
associations. The forest plots could then become Supplementary Figures. 
We have amended the Figures. Full forest plots have been moved to supplementary material. 
Similar summarized figures could be provided for the sex-specific analyses, and for the sensitivity 
analyses omitting the HUNT study and the study of reference 39, so that the results were provided for 
reference (rather than "results not shown" - if the time has been taken to produce the results, it would 
seem that little additional effort would be required to present the results). 
We have added most of the sensitivity analyses to the supplementary material. Sex-stratified 
analyses are not shown. These were not very informative, given the low power for these 
analyses. 
Reviewer: 2 
For a valid Mendelian randomization analysis, certain assumptions have to be fulfilled. The authors 
should describe in more details how these assumptions were assessed in the Methods, or if they 
were assessed previously, corresponding references should be provided. The absence of pleotropy, 
one of these assumptions, is not depicted in Figure 1. 
As discussed above, evidence for a robust association between genetic variant and smoking 
heaviness is well known in the literature. The pleiotropy assumption, as discussed in the 
paper, is assessed directly in our analysis by looking at associations between the variant and 
depression and anxiety in the never smokers. We have mentioned this in the methods section: 
“The analysis in never smokers is a test of a key assumption of Mendelian randomisation: that the 
gene only operates on the outcome through its effects on smoking heaviness (i.e., no pleiotropy). If 
rs16969968/rs1051730 only operates on an outcome measure through smoking heaviness, no 
association should be observed in never smokers.” 
Mendelian randomization analysis can be implemented in two ways, 1) Using genetic polymorphisms 
as proxies of exposure; or 2) Instrumental variable analysis using genetic polymorphisms as 
instrument. There has been some discussion on the utility of these approaches recently 
(Methodological challenges in Mendelian randomization published in Epidemiology, 2014). Can the 
authors explain why they choose the first approach over the second approach in this study? 
We have explained this in the discussion (page 18): 
“For the same reason, we did not perform instrumental variable analysis to estimate the 
magnitude of the causal effect of smoking heaviness on depression or anxiety. It has been 
demonstrated that using cigarettes per day as an intermediate variable in Mendelian 
randomisation analyses using rs16969968/rs1051730 can lead to large biases in causal effect 
size estimates 49.” 
The observational analysis is highly prone to confounding as only a few factors were adjusted for in 
this analysis. Therefore, even the result of a meta analysis is likely to be biased by methodological 
issues described in the Introduction. Can the authors adjust for more potential confounders such as 
sociodemographic factors in each of the study included? 
We see little benefit in doing this as the observational estimates are still likely to be subject to 
residual confounding. We are using Mendelian randomisation to try to minimise confounding. 
As the Mendelian randomization analysis only showed smoking heaviness (not smoking status) not 
associated with depression and anxiety among smokers, the conclusion in the abstract should be 
rephrased for better clarity. 
We have rephrased the conclusion in the abstract. 
Inconsistencies in referencing style in the reference list, and typos in the author (Davey Smith G 
instead of Smith GD) 
This is due to automatic referencing software and will be best corrected in the final version of 
the document. 
